|
Delayed
Nasdaq Stockholm
20:00:00 22/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.4940 SEK | -0.40% |
|
-0.40% | -98.75% |
| 10-26 | Biosergen Completes Merger with Flerie | MT |
| 10-26 | Merger between Flerie and Biosergen completed | FW |
| 1 day | -0.40% | ||
| 1 week | -0.40% | ||
| Current month | -4.08% | ||
| 1 month | -6.79% | ||
| 3 months | -92.10% | ||
| 6 months | -95.11% | ||
| Current year | -98.75% |
| 1 month | 0.47 | 0.53 | |
| Current year | 0.47 | 47.8 | |
| 1 year | 0.47 | 50.5 | |
| 3 years | 0.47 | 141 | |
| 5 years | 0.47 | 870 | |
| 10 years | 0.47 | 2,300 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tine Olesen
CEO | Chief Executive Officer | - | 01/02/2024 |
Mark Beveridge
DFI | Director of Finance/CFO | 48 | 24/07/2025 |
Peder Andersen
CEO | Chief Executive Officer | 74 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Marianne Kock
BRD | Director/Board Member | 71 | 01/01/2021 |
| Director/Board Member | 59 | 01/01/2021 | |
Anna Ljung
CHM | Chairman | 46 | 14/06/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.40% | -0.40% | - | - | 143K | ||
| -2.49% | -3.76% | +53.38% | +62.10% | 63.66B | ||
| -0.63% | -2.91% | +6.55% | +89.34% | 58.56B | ||
| -2.37% | -2.22% | +21.77% | +84.58% | 54.19B | ||
| -2.19% | -6.15% | +12.43% | +111.40% | 44.66B | ||
| -1.89% | -7.28% | +9.30% | +18.50% | 40.51B | ||
| -0.93% | -0.47% | +19.34% | +41.83% | 36.27B | ||
| +1.11% | -6.44% | +127.46% | +675.37% | 34.87B | ||
| -0.80% | +0.61% | +76.27% | +61.80% | 32.26B | ||
| -2.17% | +16.65% | -28.89% | +479.93% | 31.01B | ||
| Average | -1.28% | -1.22% | +33.07% | +180.54% | 44B | |
| Weighted average by Cap. | -1.48% | -1.85% | +31.83% | +155.14% |
Employees
1
- Stock Market
- Stocks
- BIOSGN Stock
Select your edition
All financial news and data tailored to specific country editions
















